Applicability of the REDUCE‐IT trial to the FAST‐MI registry. Are the results of randomized trials relevant in routine clinical practice?

BACKGROUND: The reduction of cardiovascular events with icosapent ethyl‐intervention trial (REDUCE‐IT) trial revealed robust atherosclerotic cardiovascular risk reduction with a strategy comprising high‐dose omega‐3 icosapent ethyl vs placebo in statin‐treated patients with elevated triglycerides an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrières, Jean, Bataille, Vincent, Puymirat, Etienne, Schiele, François, Simon, Tabassome, Danchin, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661650/
https://www.ncbi.nlm.nih.gov/pubmed/32720384
http://dx.doi.org/10.1002/clc.23437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661650/
https://www.ncbi.nlm.nih.gov/pubmed/32720384
http://dx.doi.org/10.1002/clc.23437

Ejemplares similares